Pr Michel Ducreux
@ducreuxmichel.bsky.social
Head of the Gastrointestinal Oncology Unit. Gustave Roussy Cancer Center. Paris-Saclay University, France
FLOT + durvalumab new perioperative treatment of localised gastric cancer
June 1, 2025 at 8:24 PM
FLOT + durvalumab new perioperative treatment of localised gastric cancer
Confirmation of the pronostic role of positive ctDNA in resected colon cancer... a large US study
May 30, 2025 at 9:08 PM
Confirmation of the pronostic role of positive ctDNA in resected colon cancer... a large US study
ASCO meeting starting today in Chicago
May 30, 2025 at 7:34 PM
ASCO meeting starting today in Chicago
Nivolumab + Ipilimumab better than nivoluma in the treatment of metastatic MSI patients. Results presented by T André at GI ASCO. Significant improvement in PFS
January 25, 2025 at 10:04 PM
Nivolumab + Ipilimumab better than nivoluma in the treatment of metastatic MSI patients. Results presented by T André at GI ASCO. Significant improvement in PFS
Aspirin 160 mg daily reduced by 50% the recurrence rate of colorectal cancer patients with PI3K mutated tumours
January 25, 2025 at 5:57 PM
Aspirin 160 mg daily reduced by 50% the recurrence rate of colorectal cancer patients with PI3K mutated tumours